Physician profile
William J Comai
NPI 1780683565
$420.81
in general payments reported to CMS, 2019-2025
13 companies · $43.93 in 2025
The $43.93 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $226 · 2020: $69.66 · 2023: $37.83 · 2024: $43.11 · 2025: $43.93.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $101 · Education: $24.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $100.87 |
| Education | $24.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $141.96 | 2019-2025 | Mako, Pangea |
| Kci USA, INC. | $69.66 | 2020 | |
| Pacira Therapeutics, INC. | $49.70 | 2019 | |
| Kaleo, INC. | $38.61 | 2019 | |
| Smith+Nephew, INC. | $19.05 | 2019 | |
| Medtronic USA, INC. | $15.69 | 2019 | |
| Alk-Abello, INC | $14.06 | 2019 | |
| Janssen Pharmaceuticals, INC | $12.90 | 2019 | |
| Avanos Medical | $12.88 | 2019 | |
| Sanofi-Aventis U.S. LLC | $12.86 | 2019 | |
| Alexion Pharmaceuticals, INC. | $11.37 | 2019 | |
| Ferring Pharmaceuticals INC. | $11.05 | 2019 | |
| Optinose US, INC. | $11.02 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Comai listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.